
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
VAX2 CRISPR/Cas9 KO Plasmid (h) | sc-407255 | 20 µg | $397.00 |
VAX2 (ventral anterior homeobox 2) encodes a homeobox transcription factor that regulates gene expression programs required for embryonic patterning of the ventral retina and optic stalk. It functions within developmental transcriptional networks that intersect with morphogen signaling, including gradients of Sonic hedgehog (SHH) and retinoic acid, to establish dorsoventral identity and neuroepithelial fate decisions. By controlling spatially restricted transcription in the developing eye, VAX2 helps coordinate retinal cell differentiation, axon guidance, and optic nerve formation. Dysregulated VAX2 expression or altered regulatory circuitry has been associated with congenital ocular malformations and neurodevelopmental phenotypes, making it a useful node for studying human eye development and disease-relevant differentiation pathways.
VAX2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the VAX2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the VAX2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the VAX2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish VAX2 protein expression.
This CRISPR knockout system enables efficient generation of VAX2-deficient cell models for investigation of VAX2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.